Loading…
Vyome Holdings, Inc. is projected to rise to $2.65 by 2027, a +23% move from its current price of $2.17. HIND is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $2.09 | $2.17 | $2.24 | +0.07% |
| Aug 6 | $2.06 | $2.17 | $2.28 | +0.13% |
| Aug 7 | $2.04 | $2.17 | $2.31 | +0.20% |
| Aug 8 | $2.02 | $2.17 | $2.33 | +0.26% |
| Aug 9 | $2.01 | $2.17 | $2.35 | +0.33% |
| Aug 10 | $1.99 | $2.17 | $2.37 | +0.40% |
| Aug 11 | $1.98 | $2.17 | $2.39 | +0.46% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.98 | $2.17 | $2.39 | +0.46% |
| Week 2 | $1.92 | $2.19 | $2.49 | +0.93% |
| Week 3 | $1.87 | $2.20 | $2.58 | +1.39% |
| Week 4 | $1.83 | $2.21 | $2.66 | +1.86% |
| Week 5 | $1.80 | $2.22 | $2.73 | +2.33% |
| Week 6 | $1.77 | $2.23 | $2.80 | +2.80% |
| Week 7 | $1.75 | $2.24 | $2.86 | +3.28% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Vyome Holdings, Inc. is a clinical-stage specialty pharmaceutical company focused on immuno-inflammatory and rare diseases in the United States. It operates through Pharmaceutical and Biotechnology segments.
Its lead product VT-1953 is a dual DNA Gyrase/Topoisomerase inhibitor and immunomodulator in a topical gel formulation that is in phase 2 clinical stage for the treatment of bacterial conjunctivitis. It also develops VT-1908, a topical eye drop is an inosine 5'-monophosphate dehydrogenase enzyme inhibitor to treat immunoinflammatory conditions of the eye; and VB-1953, which is in phase 2 clinical stage for the treatment of inflammatory acne.
In addition, the company develops antifungal products using the molecular replacement therapy (MRT) platform. It has a collaboration and license agreement with Sun Pharma Laboratories Limited to develop and commercialize next-generation antifungal products. The company is based in Cambridge, Massachusetts.
Vyome Holdings, Inc. (HIND) is in the Healthcare sector with a current price of $1.99 and a market cap of $13.97M. Its rank is 4766 among listed securities.
The near-term price outlook shows a Neutral stance in 2026 with an average price of $1.99, and a range from $1.89 to $2.88. The forecast then shifts to a Bullish tilt in subsequent years as averages rise and max values extend higher.
Longer-term expectations project higher price levels, with 2040 averaging $4.19 and 2050 averaging $6.12, while maxes reach $7.72 in 2040 and $12.52 in 2050. These figures imply meaningful upside potential over the extended horizon, albeit with year-to-year variability and uncertainty.
A major floor 15.7% below — a decisive break under it would weaken the trend.
The nearest floor, 8.1% below — buyers have tended to step in here.
The nearest ceiling, 6.2% above — a clean break opens room to run.
A major ceiling 12.9% above — clearing it would confirm fresh momentum.
Key HIND support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of HIND market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $2.02 | Buy | $2.05 | Buy |
| MA 10 | $2.08 | Buy | $2.08 | Buy |
| MA 20 | $2.14 | Buy | $2.11 | Buy |
| MA 50 | $2.19 | Sell | $2.17 | Sell |
| MA 100 | $2.18 | Sell | $2.86 | Sell |
| MA 200 | $3.10 | Sell | $53.93 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 48.81 | Neutral |
| Stoch RSI (14) | 64.98 | Neutral |
| CCI (20) | -25.71 | Neutral |
| Williams %R (14) | -55.36 | Info |
| MACD (12,26,9) | -0.01 | Sell |
| ROC (12) | -6.83 | Sell |
| Bollinger %B (20,2) | 0.42 | Neutral |
| Stochastic %K (14) | 44.64 | Neutral |
| TRIX (15) | -0.17 | Sell |
| Awesome (5,34) | -0.14 | Sell |
| Ultimate (7,14,28) | 46.46 | Neutral |
| Momentum (10) | -0.04 | Sell |
| Aroon Osc (25) | -72.00 | Sell |
| Hull MA (9) | 2.00 | Buy |
| ADX (14) | 11.56 | Neutral |
| ATR (14) | 0.05 | Info |
The 30-day technical picture is Bearish, with RSI(14) at 40. The market shows downward pressure as it trades below a near-term benchmark.
The 50-day simple moving average sits at $2.17 and the 200-day simple moving average sits at $3.18, suggesting the longer-term trend remains downward-biased despite any near-term moves.
Support is indicated at $2.00 and resistance at $2.30, with a 30-day price range of $1.58 to $2.51. These levels frame a cautious near-term outlook.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.89 | $2.17 | $3.10 | 0% | Neutral | |
| $2.06 | $2.65 | $3.64 | +23% | Bullish | |
| $2.17 | $2.90 | $4.18 | +34% | Bullish | |
| $2.06 | $2.84 | $4.23 | +31% | Bullish | |
| $1.77 | $2.51 | $3.86 | +16% | Neutral | |
| $1.75 | $2.54 | $4.01 | +17% | Neutral | |
| $1.82 | $2.71 | $4.38 | +25% | Bullish | |
| $2.11 | $3.21 | $5.29 | +48% | Bullish | |
| $2.23 | $3.47 | $5.83 | +60% | Bullish | |
| $2.17 | $3.45 | $5.90 | +59% | Bullish | |
| $2.58 | $4.51 | $8.30 | +108% | Bullish | |
| $3.20 | $6.63 | $13.58 | +206% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $1.89 | $2.17 | $2.77 | +0.00% |
| September 2026 | $1.98 | $2.37 | $2.91 | +9.28% |
| October 2026 | $1.91 | $2.30 | $2.87 | -2.83% |
| November 2026 | $1.91 | $2.31 | $2.92 | +0.50% |
| December 2026 | $2.00 | $2.43 | $3.10 | +5.34% |
Click any year to see its month-by-month HIND forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect HIND to range from $1.89 to $3.10 through 2026. The $2.17 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The HIND price prediction for 2027 points to an average of $2.65 (low $2.06, high $3.64) — a potential gain of +23% on today's $2.17. Buyers look set to stay in control over this stretch.
In 2028, HIND is projected to trade between $2.17 and $4.18, averaging $2.90 — a potential gain of +34% from today's $2.17. That is up +9% on the projected 2027 average. Momentum favours further upside here.
Vyome Holdings, Inc.'s 2029 outlook centres on $2.84, within a $2.06 to $4.23 range. That is -2% versus the projected 2028 average. That marks a +31% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, HIND could reach as high as $3.86, with a base case around $2.51 and support toward $1.77 — roughly +16% from $2.17. Price action looks broadly range-bound.
Expect HIND to range from $1.75 to $4.01 through 2031. The $2.54 average target implies a +17% move from current prices. That is up +1% on the projected 2030 average. A consolidation phase looks the most probable path here.
The HIND price prediction for 2032 points to an average of $2.71 (low $1.82, high $4.38) — a potential gain of +25% on today's $2.17. Momentum favours further upside here.
In 2033, HIND is projected to trade between $2.11 and $5.29, averaging $3.21 — a potential gain of +48% from today's $2.17. That is up +18% on the projected 2032 average. Buyers look set to stay in control over this stretch.
Vyome Holdings, Inc.'s 2034 outlook centres on $3.47, within a $2.23 to $5.83 range. That is up +8% on the projected 2033 average. That marks a +60% change versus current levels. Momentum favours further upside here.
By 2035, HIND could reach as high as $5.90, with a base case around $3.45 and support toward $2.17 — roughly +59% from $2.17. Buyers look set to stay in control over this stretch.
Expect HIND to range from $2.58 to $8.30 through 2040. The $4.51 average target implies a +108% move from current prices. That is up +31% on the projected 2035 average. Momentum favours further upside here.
The HIND price prediction for 2050 points to an average of $6.63 (low $3.20, high $13.58) — a potential gain of +206% on today's $2.17. Buyers look set to stay in control over this stretch.
Investing $1,000 in HIND today (≈ 461.893764 HIND) could be worth
$3,064.55
+$2,064.55 (+206%) by 2050 · US Dollar
Based on the average projected HIND price of $6.63 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in HINDwould be worth at today's price.
$1,000 invested in HIND on Jul 31, 2025 (≈ 102.459014 HIND) would be worth
$221.82
-$778.18 (-77.8%) today · 0.22× · US Dollar
Based on a HIND entry price of $9.76 vs. today's $2.17.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $2.06 | $1,050.97 | +5.1% |
| 1 month ago | $2.25 | $962.22 | -3.8% |
| 3 months ago | $1.96 | $1,104.59 | +10.5% |
| 6 months ago | $2.2 | $984.09 | -1.6% |
| 1 year ago | $9.76 | $221.82 | -77.8% |
| All time (5.0y) ago | $1,119,400 | $0 | -100.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our HIND forecast.
Our base-case forecast reaches $4.30 around 2040.
Implied market cap at $4.30: $30.18M
The multi-year forecast paints a variable but generally upward path after a neutral start in 2026. The 2026 outlook is Neutral, with an average of $1.99 and a 0% ROI.
From 2027 through 2029 the forecast turns Bullish, with 2027 at an average of $2.43 and 2029 at $2.61, supported by ROI figures of 22.1% and 31.4% respectively.
In 2030 the average price is projected to $2.28 (ROI 14.6%, Neutral), then 2031 at $2.36 (18.6%), 2032 at $2.52 (26.5%), 2033 at $2.93 (47.1%), 2034 at $3.21 (61.4%), and 2035 at $3.19 (60.4%), all Bullish.
The forecast shows continued upside in 2040 with an average of $4.19 (ROI 110.7%, Bullish) and in 2050 with an average of $6.12 (ROI 207.4%, Bullish). These are estimates and not guarantees, and actual results will depend on a range of factors including development progress, regulatory outcomes, and market dynamics.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $2.28 with a range from $1.61 to $3.51 and an ROI of 14.6% (sentiment Neutral).
The forecast unfolds a Neutral start in 2026, then Bullish progression in 2027–2029 and again later years, with strong upside in 2040 (avg $4.19) and 2050 (avg $6.12) including high max values; these are estimates and not guarantees.
Yes. The forecast shows values above $3 in several years, with 2033 having an avg of $2.93 and a max of $4.83, 2034 at $3.21, and 2035 at $3.19.
Current price is $1.99 and market cap is $13.97M.
Bearish sentiment with RSI 40; 50-day SMA is $2.17 and 200-day SMA is $3.18. Support is $2.00, resistance is $2.30, and the 30-day range is $1.58 to $2.51.
Vyome Holdings, Inc. Community Discussion
0Share your Vyome Holdings, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.